G13.2

Systemic atrophy primarily affecting the central nervous system in myxedema

Billable / specific

G13.2 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Excludes2

Not included here — may be reported together when both conditions exist.

  • certain conditions originating in the perinatal period (P04-P96) (from G13)
  • certain infectious and parasitic diseases (A00-B99) (from G13)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A) (from G13)
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) (from G13)
  • endocrine, nutritional and metabolic diseases (E00-E88) (from G13)
  • injury, poisoning and certain other consequences of external causes (S00-T88) (from G13)
  • neoplasms (C00-D49) (from G13)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from G13)

Code first

Sequence the underlying condition first.

  • underlying disease, such as:
  • hypothyroidism (E03.-)
  • myxedematous congenital iodine deficiency (E00.1)

Parent code

  • G13Systemic atrophies primarily affecting central nervous system in diseases classified elsewhereHeader

Related codes

  • G13.0Paraneoplastic neuromyopathy and neuropathyBillable
  • G13.1Other systemic atrophy primarily affecting central nervous system in neoplastic diseaseBillable
  • G13.8Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhereBillable

Browse